Our expertise

1. BIODERMA IS A NAOS BRAND

 

Ecobiology at the service of dermatology. To preserve skin health. Lastingly.

BIODERMA is a NAOS brand.

Ecobiology is at the heart of NAOS approach to better preserve the skin ecosystem and to strengthen its natural mechanisms. Rather than over-treating the skin, it must be taught to function properly… From this idea, the brands BIODERMA, INSTITUT ESTHEDERM and ETAT PUR were born. Each of the brands‘ mission contributes to NAOS broader ambition.

NAOS is a purpose-driven company inspired by a claimed humanist utopia. A way of looking at the world, the constant desire to question and challenge the status quo in order to build a future that will never forget its ultimate aim: humankind.

Today, operating in 100 countries and still as fiercely independent as ever, NAOS has the ambition to become globally known for the universal value and the originality of its approach. To achieve this goal, NAOS will be extending its scope from Skincare to Human Care (Health, Beauty, Well-being).

www.naos.com 

2. BIODERMA PHILOSOPHY

BIOLOGY & DERMATOLOGY

 

BIODERMA, DERMATOLOGICAL LABORATORY
A pioneer since the 1970s, BIODERMA has acquired unique expertise by placing biology at the service of dermatology. This original scientific approach relies first and foremost on knowledge of the skin and its biological mechanisms to formulate products directly inspired by them.

OUR MODEL

A SINGLE MODEL: HEALTHY SKIN
All BIODERMA research revolves around the study of healthy skin and its cells and imbalances. The skin speaks its own language and BIODERMA tirelessly seeks to understand it. It is subject to changes and environmental stresses. Therefore, diseases, medicated treatments, aging and many other factors may affect its balance and cause it to malfunction. BIODERMA’s approach involves reactivating the skin’s natural resources to help it resist and recover its normal functions, which are those found in healthy skin.

OUR CONCEPT

A UNIQUE CONCEPT, BIOLOGICAL MIMETISM
Based on total respect for the skin, BIODERMA products imitate its natural biological mechanisms through their components and their modes of action. To formulate them, BIODERMA selects the purest active ingredients, using molecules naturally found in the skin for better tolerance. Depending on the malfunction, BIODERMA products preserve, activate or restore the skin’s natural processes.

OUR MISSION

AN ABSOLUTE REQUIREMENT, THE DERMATOLOGICAL SAFETY
BIODERMA has always sought to reconcile perfect effectiveness and better tolerance for each skin type and each condition. In order to guarantee the greatest dermatological safety, BIODERMA products contain a very limited number of ingredients and optimally dosed active ingredients. Pre-empting the recommendations of the health authorities, BIODERMA tends to exclude all dermatologically questionable products. These commitments are reflected in a formulation charter that applies to all product developments and grounds their superiority in a scientific method. This uncompromising approach explains why BIODERMA products improve the skin’s tolerance and help it be less reactive. That is why they all benefit from the DAF (Dermatological Advanced Formulation) patented natural complex.

 

THE BIODERMA CHARTER IS MADE UP OF 8 EXCLUSIVE PRINCIPLES

  1. Biological patents

    All BIODERMA products are formulated with teams of biologists and dermatologists. They rely on a biological mode of action that acts on the causes and consequences of the dermatological condition to correct it over the long term.

  2. Skin tolerabilty

    BIODERMA formulas improve the skin’s tolerability and boost its resistance to its environment through the development of a unique patent: D.A.F., Dermatological Advanced Formulation.

  3. Dermatological safety

    3 hard and fast rules for perfect effectiveness and better tolerance: use only ingredients that are strictly necessary, select optimal doses of the purest active ingredients, prefer molecules already found in the skin.

  4. Scientifically recognised active ingredients

    The ingredients and components used by BIODERMA meet the two basic criteria for our formulas: biological effectiveness and dermatological safety.

     

  5. Principle of precaution

    BIODERMA tends to exclude dermatologically questionable products and ingredients: parabens, phthalates, formol, formaldehyde, etc..

  6. Safety and efficacy tests

    Each BIODERMA product adheres to the most rigorous recommendations issued by the health authorities and leading dermatology companies.

  7. Clinical trials

    All BIODERMA care products are subject to clinical studies undertaken under the supervision of expert dermatologists, allergologists and toxicologists. These studies are then published in reference scientific journals.

  8. Total traceability

    BIODERMA is committed to monitoring the origin and ensuring the total traceability of its components and products through compliance with the standards in force in the cosmetic industry.

3. THE LABORATORY’S HISTORY

THE LABORATORY’S HISTORY, A VISIONARY AND GENEROUS BRAND

The BIODERMA brand has always remained true to its convictions, followed its intuition and defended its spirit of independence. The Laboratory has maintained the same sincere passion to understand the biology of the skin and the same desire to innovate and take part in dermatological breakthroughs, far from preconceived notions and established dogma.

 

A PHARMACIST & A CONCEPT

It all began in the 1970s with Jean-Noël Thorel, a pioneering pharmacist who came up with a radically new approach to dermo-cosmetics, thanks to his close conversations with the world’s leading experts in biology and dermatology. He developed his first patents and laid the foundations for the BIODERMA philosophy: biology at the service of dermatology.

 

1977, THE 1ST BREAKTHROUGH INNOVATION

Symbolising BIODERMA’s innovation strategy, the Nodé shampoo was a first breakthrough on its market and would later be followed by many other BIODERMA product innovations. The name Nodé came from “NOn-DEtergence” and underlined the originality of its formula, which for the first time could cleanse the hair without attacking it. This patent respected the physiology of the hair bulb and preserved the lipidic film of the fiber and scalp. Offering more softness and better tolerance, the original product and the whole Nodé range are huge successes still to this today.

 

SINCE 1985, A DYNAMIC OF INNOVATION WITH HEALTH PROFESSIONALS

Eight years after the first products were marketed in pharmacies, the brand developed a real product range in close collaboration with dermatologists. Sharing the same biological approach to the skin, BIODERMA has always referred to doctors’ expectations to develop its products and to their requirements to develop its formulas and formulations. Still today, this collaborative work guarantees the relevance of BIODERMA innovations for patients. At the same time, close relationships were established with dispensaries, thus providing valuable feedback about products and how they were perceived by consumers.
In 1992, the BIODERMA Laboratory became independent to preserve its freedom of action and its strategy. Jean-Noël Thorel, the brand’s founder, surrounded himself with a team of researchers and scientists driven by the same vision and fascinated by biology who were determined to advance dermatology.

 

1992, THE AGE OF MAJOR INNOVATIONS

“We are builders in our area of expertise: the skin, biology, dermatology. Our vision, the way we proceed, is different from that of the others because we don’t stop at simply correcting skin dysfunction, we aim to protect the skin’s resources and enable the skin to adapt to its environment and lifestyle, over time. The way we do things is as essential as the things we do. Our existence, our relationships with others are based on this raison d’être”. The brand still remains driven by Jean-Noël Thorel’s convictions. All BIODERMA innovations start with the skin, its functions and its biology. Since the beginning and even more so since the 1990s, the laboratory has designed benchmark products based on key innovations offering new options to meet the expectations of dermatologists and the needs of their patients. These innovations have covered the areas of sensitive skin, oily skin, dry skin, dehydrated skin, photoprotection, hair and cell regeneration.

 

2001, A GLOBAL REACH

The opening of the first subsidiary in Italy in 2001 officially marked the internationalization of the BIODERMA Laboratory’s activities, which had begun in the 1990s. Such a change of scale was made necessary by a will to remain as close as possible to each market’s realities. The objective: understand the expectations of dermatologists, pharmacists and their patients, which vary considerably from one country to another. Respect geographic, cultural and physiological differences and adapt to the practices of healthcare professionals all over the world. The BIODERMA Laboratory is currently present in nearly 100 countries, through subsidiaries, points of sale, associate research centers, private partnerships and universities.

 

2009, SOCIALLY-RESPONSIBLE COMMITMENT

In November 2009, the BIODERMA Laboratory carried out its first socially-oriented mission in North Vietnam. It has since undertaken a series of missions in Vietnam and Cambodia with the help of French doctors – mainly dermatologists – and pharmacists, and various humanitarian associations. The aim: provide local populations with medical assistance, computing resources and miscellaneous materials. All these actions reflect the spirit that drives the BIODERMA Laboratory from day to day and express the profoundly human values it defends: generosity, solidarity and sharing.

 

2011, ADVANCING DERMATOLOGY WITH THE BIODERMA FOUNDATION

Created in 2011, the BIODERMA Foundation, sponsored by the Fondation de France, has the essential mission of supporting the development of dermatology around the world. It represents the culminating point for a brand that has always relied on dermatologists to move forward. Coming full circle, the BIODERMA Foundation actively helps disseminate knowledge of dermatology among doctors all over the world and advance fundamental biology research through an ethical and socially-responsible approach.  A symbol of the BIODERMA Foundation’s commitment to dermatology, the “World Rendez-Vous on Dermatology” is a unique annual meeting place for top specialists from all continents for first-rate exchanges and transfers of know-how.

4. INNOVATION AND RESEARCH

BIOLOGY AT THE SERVICE OF DERMATOLOGY

At the heart of the BIODERMA Laboratory’s approach, Research & Development harnesses all efforts to continuously remain at the forefront of scientific knowledge in biology and dermatology. After years of work alongside top international medical experts, BIODERMA has become a key player and plays a decisive role in the implementation of research breakthroughs for skin diseases. It collaborates with researchers and physicians in each stage of a product’s development.

 

ALWAYS FURTHER IN BIOLOGY

BIODERMA’s mission has always been to better understand the skin and especially understand how healthy skin works to know how to rebalance it when it malfunctions. Indeed, real expertise in skin biology is required to understand the causes before treating the consequences. Upstream, BIODERMA teams work in close collaboration with national and international scientists and laboratories with advanced expertise in skin biology. Ongoing progress in fundamental research provides keys to better understand the causes of skin imbalances and paves the way for dermatological innovations.

 

MEETING EXPECTATIONS IN DERMATOLOGY

In the past, BIODERMA always relied on clinical research to develop product innovations, and this is still true today. Essential sources of information, dermatologists further BIODERMA’s research by identifying skin problems requiring new responses. The partnership then continues throughout the innovation process to validate the safety and effectiveness of each new product. Clinical trials in hospitals take all aspects into account, from tolerance to the most suitable formulation. The BIODERMA Laboratory frequently publishes scientific and clinical studies together with major international laboratories.

 

BIODERMA INNOVATION’S

Daily, many factors weaken skin: UV rays are strong free radical inducers that cause skin aging in the long term; toxic irritant chemical agents (preservatives, some colorant, emulsifiers…); external factors (wind, cold, heat). They make skin barrier extremely fragile. Skin loses its protection function. Skin is weakened. It becomes more reactive. It reddens easily and can sometimes develop allergies. Today, two out of three women report having sensitive skin.

THE BIODERMA INNOVATION
The exclusive natural patented complex D.A.F. reinforces skin tolerability.
Day after day, skin is more resistant and impermeable to external aggressions.
D.A.F. is an exclusive combination of 5 active ingredients that work in a synergistic and complementary manner in order to make skin more resistant.
Its biological function consists in:
• Reducing skin reactivity with Seaweed extract (Laminaria Ochroleuca) and Rhamnose
• Limiting the number of free radicals with Mannitol: a powerful antiradical
• Protecting the skin from noxious agents with Xylitol to restore skin impermeability to allergens penetrate it
• Limiting the use of preservatives with Oligo Fructo Saccharides